BIOMAT Database Logo BIOMAT Database Logo

Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. 2014

F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.

Signals from the tumor microenvironment trigger cancer cells to adopt an invasive phenotype through epithelial-mesenchymal transition (EMT). Relatively little is known regarding key signal transduction pathways that serve as cytosolic bridges between cell surface receptors and nuclear transcription factors to induce EMT. A better understanding of these early EMT events may identify potential targets for the control of metastasis. One rapid intracellular signaling pathway that has not yet been explored during EMT induction is calcium. Here we show that stimuli used to induce EMT produce a transient increase in cytosolic calcium levels in human breast cancer cells. Attenuation of the calcium signal by intracellular calcium chelation significantly reduced epidermal growth factor (EGF)- and hypoxia-induced EMT. Intracellular calcium chelation also inhibited EGF-induced activation of signal transducer and activator of transcription 3 (STAT3), while preserving other signal transduction pathways such as Akt and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation. To identify calcium-permeable channels that may regulate EMT induction in breast cancer cells, we performed a targeted siRNA-based screen. We found that transient receptor potential-melastatin-like 7 (TRPM7) channel expression regulated EGF-induced STAT3 phosphorylation and expression of the EMT marker vimentin. Although intracellular calcium chelation almost completely blocked the induction of many EMT markers, including vimentin, Twist and N-cadherin, the effect of TRPM7 silencing was specific for vimentin protein expression and STAT3 phosphorylation. These results indicate that TRPM7 is a partial regulator of EMT in breast cancer cells, and that other calcium-permeable ion channels are also involved in calcium-dependent EMT induction. In summary, this work establishes an important role for the intracellular calcium signal in the induction of EMT in human breast cancer cells. Manipulation of calcium-signaling pathways controlling EMT induction in cancer cells may therefore be an important therapeutic strategy for preventing metastases.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014746 Vimentin An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.
D015687 Cell Hypoxia A condition of decreased oxygen content at the cellular level. Anoxia, Cellular,Cell Anoxia,Hypoxia, Cellular,Anoxia, Cell,Anoxias, Cell,Anoxias, Cellular,Cell Anoxias,Cell Hypoxias,Cellular Anoxia,Cellular Anoxias,Cellular Hypoxia,Cellular Hypoxias,Hypoxia, Cell,Hypoxias, Cell,Hypoxias, Cellular
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
October 2008, Developmental dynamics : an official publication of the American Association of Anatomists,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.
December 2017, Cancer microenvironment : official journal of the International Cancer Microenvironment Society,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling.
August 2009, The Journal of biological chemistry,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Epithelial-Mesenchymal Transition (EMT).
July 2023, International journal of molecular sciences,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
December 2023, Medical oncology (Northwood, London, England),
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Atropine Is a Suppressor of Epithelial-Mesenchymal Transition (EMT) That Reduces Stemness in Drug-Resistant Breast Cancer Cells.
August 2022, International journal of molecular sciences,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Epithelial-Mesenchymal Transition (EMT) and Prostate Cancer.
January 2018, Advances in experimental medicine and biology,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Mummy Induces Apoptosis Through Inhibiting of Epithelial-Mesenchymal Transition (EMT) in Human Breast Cancer Cells.
January 2020, Galen medical journal,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.
June 2010, Journal of mammary gland biology and neoplasia,
F M Davis, and I Azimi, and R A Faville, and A A Peters, and K Jalink, and J W Putney, and G J Goodhill, and E W Thompson, and S J Roberts-Thomson, and G R Monteith
The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer.
September 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Copied contents to your clipboard!